However, in head and neck SCC (HNSCC), including OSCC, most genetic mutations are associated with tumor suppressor genes such as TP53, and genetic mutations in the PI3K/AKT or RAS/RAF pathways are rare [1, 25–32]. This evidence concerns the gene AKT1 and neoplasm.